Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Recursion, a clinical stage TechBio company, focuses on decoding biology to significantly enhance lives [1] - The CEO, Najat Khan, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 [1] - The company will also participate in the 28th Annual Needham Growth Conference on January 16, 2026 [1] Company Overview - Recursion is headquartered in Salt Lake City and is a founding member of BioHive, a collective for the Utah life sciences industry [2] - The company has additional offices in Montréal, New York, London, and the Oxford area [2] - Recursion utilizes a platform called Recursion OS, which generates one of the largest proprietary biological and chemical datasets globally [1] - The company employs advanced machine-learning algorithms to identify trillions of relationships in biology and chemistry, free from human bias [1] - Recursion conducts millions of wet lab experiments weekly and operates one of the most powerful supercomputers in the world to advance medical research [1]